We are a pharmaceutical R&D company focused on developing innovative treatments for autoimmune diseases, particularly Multiple Sclerosis. Our pipeline includes novel molecules derived from cutting-edge research at Trinity College Dublin, which have shown promise in controlling autoimmune responses i...See more
Headquarters:
New Zealand
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2016 (10 years)
Address:
UNIVERSITY ROAD; CANTERBURY INNOVATION CENTRE; CANTERBURY, KENT CT47LD, GB
LOW
spending power